Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from JNJ

Is Johnson & Johnson Underperforming the S&P 500?

Johnson & Johnson has underperformed the S&P 500 recently, but analysts are moderately optimistic about the stock’s potential.

3 Blue-Chip Stocks to Buy for Long-Term Security

3 Blue-Chip Stocks to Buy for Long-Term Security

Blue-chip stocks offer long-term security due to their strong financial stability, established market presence, and consistent performance. Amid this backdrop, it could be wise to invest in blue-chip stocks, Apple (AAPL), Johnson & Johnson (JNJ), and American Express (AXP) for long-term security. Continue reading.

3 Healthcare Stocks With Strong Buy Ratings

3 Healthcare Stocks With Strong Buy Ratings

The healthcare sector is proving to be a robust investment haven, particularly as it continues to evolve with groundbreaking technology and strong government support. Therefore, adding strong A-rated stocks like Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK) could help garner significant returns. Read more….

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Inflation-Beating Stocks for Your Portfolio

Buying inflation-beating stocks helps preserve and grow the real value of your investments by outpacing rising prices and protecting against the eroding effects of inflation. Therefore, it could be wise to add inflation-beating stocks Walmart (WMT), Costco Wholesale (COST), and Johnson & Johnson (JNJ) to your portfolio. Read more.

How High Can This Healthcare Stock Soar With Nvidia's Help?

Dividend King J&J can boost its MedTech business with Nvidia’s help.

3 Bargain Healthcare Stocks to Buy for Long-Term Gains

The healthcare sector is poised for significant growth, driven by advancements in drug development, ongoing research and development (R&D) efforts, and its ability to remain resilient even during economic downturns. Thus, investors might consider buying bargain pharma stocks: Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) for…

3 Blue-Chip Dividend Stocks for a Secure Retirement Portfolio

Blue-chip dividend stocks are of well-established companies offering steady income and financial stability. They are ideal for securing a resilient retirement portfolio, combining consistent dividends with potential capital appreciation. Thus, quality blue-chip dividend stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and McDonald’s (MCD) could be ideal portfolio additions for retirement…

inkl

Read news from The Economist, FT, and more,
with one subscription

Is It Time to Buy These Overlooked Dividend Stocks?

Is It Time to Buy These Overlooked Dividend Stocks?

These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income.

3 Must-Buy Healthcare Stocks for Defensive Investing

3 Must-Buy Healthcare Stocks for Defensive Investing

The healthcare sector is set for significant growth due to advancements in pharma technology, increasing demand for personalized medicines, and resilience even in economic downturns. Therefore, investors might consider buying quality pharmaceutical stocks like Pfizer (PFE), Johnson & Johnson (JNJ), and AbbVie (ABBV) for defensive investing. Read on.

3 Top Stocks for Dividend Reinvestment Plans (DRIPs)

3 Top Stocks for Dividend Reinvestment Plans (DRIPs)

DRIPs offer a compelling strategy to boost investment returns. This approach helps to compound your gains over time by reinvesting dividends to buy more stock and reducing risk through dollar-cost investing. Top stocks, including Johnson & Johnson (JNJ), Coca-Cola (KO), and PepsiCo (PEP), are ideal for reinvesting dividends to maximize…

Is Wall Street Bullish or Bearish on Johnson & Johnson Stock?

Is Wall Street Bullish or Bearish on Johnson & Johnson Stock?

Despite Johnson & Johnson’s relative underperformance over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

3 Healthcare Stocks Benefiting From an Aging Population

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is set for growth due to the growing demand for quality healthcare services and the aging population. Hence, quality healthcare stocks, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK), might be worth looking into. Read more….

3 Pharmaceutical Stocks With Strong Pipelines

3 Pharmaceutical Stocks With Strong Pipelines

The pharmaceutical industry is flourishing due to increasing medical demands and rising healthcare spending worldwide. Hence, pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck & Co. (MRK), with strong pipelines, might be worth buying. Read more….

Stock Market Today: Semis Get Slammed and Blue Chips Bounce

Stock Market Today: Semis Get Slammed and Blue Chips Bounce

The potential for more curbs on tech sales to China set off a rotation into blue chips.

Get all your
news in one place.

100’s of premium titles.
One news app.

3 Blue-Chip Stocks to Buy and Hold Forever

Amidst market uncertainty, blue-chip stocks provide stability, diversification, and reliable returns. Therefore, Johnson & Johnson (JNJ), International Business Machines (IBM), and AT&T (T) could be wise picks to buy and hold forever for smart investors. Read on.

Johnson & Johnson Earnings Preview: What to Expect

Johnson & Johnson is expected to release its second-quarter earnings next week, and analysts project a low single-digit profit dip.

3 Healthcare Stocks With Strong Profit Margins to Buy Now

The healthcare industry is poised to grow rapidly due to the rising need for medical aid, government initiatives, and increasing chronic diseases contributing to overall stability. Given the industry’s promising prospects, investors could consider buying quality healthcare stocks: UnitedHealth Group (UNH), Johnson & Johnson (JNJ), and AbbVie (ABBV), with strong…

3 Blue-Chip Stocks Offering Stability

Blue-chip companies, characterized by large capitalization, global footprint, solid financial performance, robust balance sheet, and dominant market position, are favored by investors seeking stability and long-term growth potential. Thus, quality blue-chip stocks Microsoft (MSFT), Procter & Gamble (PG), and Johnson & Johnson (JNJ) could be attractive buys for steady returns.…

Get all your
news in one place.

100’s of premium titles.
One news app.

How Is Johnson & Johnson's Stock Performance Compared to Other Pharmaceutical Stocks?

Johnson & Johnson has recently underperformed other pharmaceutical stocks. However, Wall Street analysts are moderately optimistic about the stock’s prospects.

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

Are Wall Street Analysts Bullish on Johnson & Johnson Stock?

As Johnson & Johnson trails the broader market, Wall Street analysts remain cautiously optimistic about the stock's prospects.

JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…

4 Pharma Giants Sparking Investor Interest

The pharmaceutical industry is growing steadily, focusing more on technological innovation, precision medicine, and strategic mergers and acquisitions (M&A). So, let’s take a look at pharma giants Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) igniting investor interest. Keep reading….

Johnson & Johnson Poised For Growth Despite Recent Challenges

Johnson & Johnson (NYSE: JNJ) poised for growth despite challenges, with analysts estimating a 10% upside. Resilient in market fluctuations, key drivers in...

4 Pharma Titans Making Waves in Wall Street

The pharma industry is well-positioned to remain buoyed, owing to the rise in chronic diseases, a growing elderly population, and the integration of advanced technologies. Given this backdrop, quality pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co. (MRK), making waves in…

People

Kritika SarmahHer

Neha PanjwaniFrom

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

340,453 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play